Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262211023 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Laura Giuseppina Di Pasqua und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and Therapeutics, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Receptors, Cytoplasmic and Nuclear, Mitochondria, Liver, Fatty Liver. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This work has been supported by FRG20SZ08-University of Pavia and by Intercept Pharmaceu-ticals, Inc., FRG20SZ08—University of Pavia, Intercept Pharmaceuticals, Inc.
Abstract (Originalsprache)
This study evaluated the protective role of farnesoid-X-receptor (FXR) agonist INT-787 in the control of mitochondrial changes using a metabolic dysfunction-associated steatohepatitis (MASH) model. Lep-ob/ob mice were fed a control diet (CD) for 21 weeks (wks), or a high-fat diet (HFD) for 9 or 21 wks; in the 21 wk HFD groups, INT-787 (30 mg/kg/day) dosed via HFD admixture was added. The hepatic ATP, ROS, GSH and MIC19, which stabilizes the structure of inner mitochondrial membrane (IMM), were quantified. Transmission electron microscopy (TEM) analysis was also performed. INT-787 increased hepatic ATP, which was downregulated after HFD 9 and 21 wks. Hepatic ROS increased and GSH decreased after 21 wks and were recovered by INT-787. MIC19 mRNA level decreased after HFD 21 wks, and it was completely restored after INT-787 administration. TEM analysis showed that INT-787 reverted the mitochondrial alterations as documented by restored mitochondrial length, number of mitochondrial cristae junctions (CJs), and distance between endoplasmic reticulum (ER) and outer mitochondrial membrane (OMM) when compared with HFD groups. These results underline the involvement of the FXR pathway in the control of mitochondrial damage, thus revealing a previously undiscovered mechanism mediated by FXR activation: the upregulation of IMM protein MIC19, which is essential for maintaining cristae integrity and mitochondrial function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and Therapeutics, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.
- Internal Medicine and Emergency Medicine Unit, Fondazione IRCCS Policlinico San Matteo, 27100 Pavia, Italy.
- Institute of Molecular Genetics, Italian National Research Council (CNR), Via Abbiategrasso 207, 27100 Pavia, Italy.
- Department of Biology & Biotechnology, University of Pavia, Via Ferrata 9, 27100 Pavia, Italy.
- Intercept Pharmaceuticals, San Diego, CA 92121, USA.
ORCID-Profile: Laura Giuseppina Di Pasqua, Giuseppina Palladini, Anna Cleta Croce, Gloria Milanesi, Margherita Cavallo, Luciano Adorini, Andrea Ferrigno, Mariapia Vairetti
Förderung
- This work has been supported by FRG20SZ08-University of Pavia and by Intercept Pharmaceu-ticals, Inc.
- FRG20SZ08—University of Pavia
- Intercept Pharmaceuticals, Inc
Zitieren
APA
Di Pasqua, L. G., Palladini, G., Croce, A. C., Milanesi, G., Cavallo, M., Adorini, L., Ferrigno, A., & Vairetti, M. (2025). Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262211023
Vancouver
Di Pasqua LG, Palladini G, Croce AC, Milanesi G, Cavallo M, Adorini L, et al. Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262211023
BibTeX
@article{DiPasqua2025,
author = {Di Pasqua, Laura Giuseppina and Palladini, Giuseppina and Croce, Anna Cleta and Milanesi, Gloria and Cavallo, Margherita and Adorini, Luciano and Ferrigno, Andrea and Vairetti, Mariapia},
title = {Farnesoid X Receptor Agonist INT-787 Inhibits Hepatic Mitochondrial Dysfunction in a Diet-Induced ob/ob Mouse Model of MASH},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262211023}
}
EUVIMED